Approval · Notice of Compliance 21585 · 2018

BELSOMRA: Notice of Compliance 21585

Issued November 29, 2018

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 21585
Date: November 29, 2018
Company: Merck Canada IncKirkland, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: New Active Substance (NAS)

Products in this notice

Brand	DIN	Status today
BELSOMRA	02483505	Cancelled Pre Market
BELSOMRA	02483513	Cancelled Post Market
BELSOMRA	02483521	Cancelled Post Market
BELSOMRA	02483548	Cancelled Post Market

Medicinal ingredients

SUVOREXANT 5 MG per TAB
SUVOREXANT 10 MG per TAB
SUVOREXANT 15 MG per TAB
SUVOREXANT 20 MG per TAB